Crossbred beef heifers (N = 36) were assigned to one of three treatment groups: untreated controls (C; N = 15); Group R4, treated with pig relaxin (1\m=.\0mg i.m.) 4 days pre partum (N = 11); or Group R7, treated with pig relaxin ( 1 \ m=. \ 0 mg i.m.) 7 days pre partum (N = 10). Bioactivity of the pig relaxin (UMC-R-P8) was determined by the mouse interpubic ligament assay to be \ m=ge\ 3000 U/mg, both before and after the experiment was conducted. Peripheral serum immunoreactive relaxin values were 7\ m=. \ 5, 3\m=.\4,2\m=.\5, and 1\m=.\5, ng/ml at 2, 4, 6 and 8 h after injection of relaxin, respectively. Gestation lengths were 282\m=.\9\m=+-\1 \ m= . \ 1 285\m=.\5\ m=+-\1\m=.\3 and 285\m=.\6\ m=+-\1\ m=. \ 5days for Groups C, R4 and R7 (C vs R4 + R7; P \ m=si meq\ 0\m=.\08).Calving difficulty score (1 to 4) tended to be greater (P \ m=si meq\ 0\m=.\08) for Group R4 and R7 heifers (C vs R4 + R7; 1\m=.\3 \ m=+-\ 0\m=.\24vs 1\m=.\75 \ m=+-\ 0\m=.\28 + 2\m=.\04\m=+-\ 0\m=.\32), but the incidences of dystocia and retained placentae were not influenced by treatment (P \m=ge\ 0\m=.\10). The mean concentration and concentration profile of daily serum progesterone, oestradiol-17\g=b\,dihydroprostaglandin F-2\g=a\and relaxin were not affected by treatment from 6 days pre partum through 2 days post partum. Cervical diameter, cervical softness score, pelvic measurements, and vulva opening length during the periparturient period were not affected (P \m=ge\ 0\m=.\10)by treatment, but all of these characteristics changed over time (P \m=l e\ 0\m=.\01), relative to calving. We conclude that i.m. administration of pig relaxin (\m=ge\3000 U) does not effectively alter periparturient characteristics of beef heifers. Discrepancies between these results and those reported for intracervical administration cannot be readily explained.
Introduction
Calf death caused by dystocia is a major factor that contributes to a reduction in net calf crop. The need for the cattle industry to maximize the total production of a cow requires that she must first calve at 2 years of age. However, dystocia is most prevalent in primiparous heifers calving at 2 years of age (Brinks et ai, 1973) . A major factor contributing to dystocia is a disproportion in the size of the fetus to the pelvic area of the dam (Bellows et ai, 1971a; Rice ¿5c Wiltbank, 1972; Price & Wiltbank, 1978b) . Calf birth weight is directly related and pelvic area is inversely related to the incidence of dystocia in cattle (Bellows et ai, 1969; Price & Wiltbank, 1978b) . Other factors associ¬ ated with calving difficulty are: age and breed of dam, breed and genotype of sire, sex and shape of calf, length of gestation, pre-partum nutrition of the dam, vulval stenosis and uterine inertia (Price & Wiltbank, 1978a) .
Relaxin is a polypeptide hormone produced primarily during pregnancy, and is produced by various reproductive organs of many species (Anderson, 1987) . Relaxin is involved in cervical dilatation (Downing & Sherwood, 1985) , relaxation of the pubic symphysis (Steinetz et ai, 1960) , inhibition of uterine contractility (Porter, 1971) , and stimulation of uterine growth (Vasilenko & Mead, 1987) . Intracervical administration of pig relaxin to primigravid beef heifers 4 or 5 days before expected parturition induced cervical dilatation and increased pelvic area Musah et ai, 1986a, b) . Additionally, when pig relaxin was administered with cloprostenol or dexamethasone 10 days pre partum, the incidence of retained placentae was reduced (Musah et ai, 1987b ) when compared to cloprostenol or dexamethasone treatment alone. It has been suggested (Musah et ai, 1987a ) that relaxin may have a direct or indirect luteolytic effect, but Caldwell et ai (1990) indicated that pig relaxin by itself was unable to induce parturition in beef cows 10 days pre partum when administered intramuscularly.
The objectives of this research were to determine the effectiveness of intramuscular pig relaxin administration to first-calf heifers in reducing the incidence of dystocia, and to determine its influence on physical and hormonal changes during the periparturient period.
Materials and Methods
Animals. Thirty-six Hereford (H) or Brahman (Br) sired crossbred heifers were mated by artificial insemination to a single Gelbvieh sire, to calve at approximately 2 years of age. The 2-year-old heifers were maintained on pasture until 30 days before their expected date of parturition, at which time they were moved to observation lots and provided a corn silage-based diet ad libitum. Expected parturition was determined to be 285 days of gestation based on perform¬ ance data of the sire. Relaxin purification. Pig relaxin was purified from late-pregnant pig ovaries by the methods of Caldwell et al. (1990) . Biological activity of the purified relaxin (UMC-R-P8) was determined both before and after experimental use in cattle, by the mouse interpubic ligament assay (Steinetz et ai, 1960) , using 20 mice per dose and NIH-R-P1 pRLX (3000 U/mg) as the reference standard. Pooled data (from before and after experimental use) from the bioassay were analysed for parallelism of the dose-response curves and relative potencies by the methods of Bliss (1952) . The relative potency of UMC-R-P8 was determined to be >3000 U/mg, and its dose-response curve was not different (P > 010) from that of NIH-R-P1 (slope = 1 -49; = 0-11 ).
Experimental design and data collection. At 30 days before expected parturition, the heifers were randomly assigned within heifer breed (H or Br) to one of three treatment groups. One group (C; = 15) served as untreated control animals; a second group (R4; = 11) received 10 mg pig relaxin (UMC-R-P8) intramuscularly (i.m.) in phosphate-buffered saline (PBS) 4 days before expected parturition; and a third group (R7; -10) received 10 mg pig relaxin (UMC-R-P8) i.m. in PBS 7 days before expected parturition. Daily blood samples, physical measurements and scores were collected on all heifers beginning 10 days before expected parturition, within 2 h of calving and through 2 days post partum. All of the following measurements and scores were obtained by a single individual and without knowledge of treatment assignment. Pelvic measurements were obtained by the methods of Bellows et al. (1971b) . External length of the vulva opening was measured using a sliding caliper, and cervical diameter was esti¬ mated by rectal palpation. Cervical softness was scored from 1 (firm and non-pliable) to 4 (soft and very pliable) via rectal palpation. Additionally, blood samples were collected from one heifer in each of Groups R4 and R7 every 2 h, beginning immediately before treatment with relaxin and continuing for 8 h after treatment to ascertain the clearance rate of relaxin after i.m. administration. At parturition calving difficulty was scored (Bellows et ai, 1971a ) from 1 (no difficulty) to 4 (extreme difficulty or Caesarean section), and calf vigour was scored on a scale of 1 (alive and vigorous) to 3 (dead). Within 2 h of parturi¬ tion, calf birth weight and maternal measurements and scores were determined. The placenta was classified as being retained if it had not been expelled within 24 h of parturition. Daily blood collection and maternal measurements continued until 2 days post partum, at which time the heifers and their calves were returned to pasture. Hormone analyses. Daily blood samples were collected from a coccygeal vessel into non-heparinized tubes. The blood samples were maintained on ice until centrifugation at 1500 g for 2 h. Resulting serum was decanted and stored at -20°C until analysed for serum progesterone, oestradiol-17ß, 15-keto-13,14-dihydro-prostaglandin F-2a (PGFM) and relaxin.
Concentrations of progesterone in 100 pi samples of non-extracted serum were determined using a Diagnostic Products Corp. (Los Angeles, CA, USA) radioimmunoassay (RIA) kit. The standard curve ranged from 40 pg/tube (93-3 ± 1-8% B/Bo) to 40ng/tube (7-2 ± 1-2% B/Bo). Intra-assay and interassay coefficients of variation were 10-1% (N = 6) and 9-7% (N = 18), respectively, for two pools of spiked ovariectomized cow serum (261 ng/ml and 4-92 ng/ml). Concentrations of serum oestradiol were determined by the RIA described by Kesler et ai (1977) in 100 pi samples. Average extraction (diethyl ether) efficiency was 95-6%, but samples were not adjusted for procedural losses. Intra-assay and inter-assay coefficients of variation were 11-4% (N = 10) and 21-1% (N = 20), respectively, for a pool of spiked ovariectomized cow serum (9-6 pg/ml). Serum PGFM concentrations were determined on 200 pi samples (non-extracted) using the RIA described by Zollers et ai (1989) . Concentrations of PGFM in a pool of ovariectomized cow sera, spiked with PGFM (3-2 ng/ml), at 50, 100 and 200 pi doses were determined to estimate intra-assay and inter-assay coefficients of variation. The intra-assay and inter-assay coefficients of variation were 9-2% (N = 15) and 18-2% (N = 30), respectively.
Relaxin concentrations were measured with an homologous RIA as described by Musah et ai (1987a) . Heifer serum samples (200 and 400pi) or pig relaxin standards (UMC-R-P8; 001, 0025, 005, 010, 0-25, 0-50, 100, and 200ng/tube in 005m-PBS-1% BSA) were quantified in duplicate by the double-antibody RIA. Monotyrosylated relaxin (Schwabe, 1983 ) was iodinated to a specific activity of 78 pCi/pg by the chloramine-T procedure (Hunter & Greenwood, 1962) and used at 25000c.p.m./tube (100pi; 005m-PBS-1% BSA). Rabbit antiporcine relaxin antiserum (Dual Rabbit R6 obtained from Dr B. G. Steinetz, New York University, Tuxedo, NY) was added to all tubes to a final titre of 1:300 000 in 005 m-PBS-6% normal rabbit serum (NRS), except total count and non-specific binding tubes. Non-specific binding tubes received 005 m-PBS-6% NRS, and all tubes were adjusted to 800 pi with 005 m-PBS-1% BSA before incubation at 4°C for 24 h. After incubation, 200 pi sheep-antirabbit antiserum (diluted 1:16 with 0-05m-PBS-1% BSA) was added to all tubes, except total count tubes, and incubated for 24 h at 4°C. The precipitated relaxin-antibody complex was harvested by centrifugation at 3000 g for 30 min, the supernatant was aspirated, and the precipitate counted in a -counter.
The maximum binding of the antibody was 29-3 ± 4-98%, and non-specific binding was 3-48 + 0-56%. Intra-and inter-assay coefficients of variation were determined to be 712% (n = 6) and 8-93% (n = 18), respectively, for a pool of ovariectomized cow serum spiked with pig relaxin (1 08 ng/ml) and assayed in 50, 100 and 200 pi samples. Accuracy and precision were evaluated by the addition of pig relaxin (UMC-R-P8) to ovariectomized cow sera at doses (in duplicate) of 001, 0025, 005, 0-10, 0-25, 0-50, 1-00, and 200ng/200pi serum (Fig. 1 ). Immunoreactive relaxin was undetectable in a pool of late-pregnant cow serum assayed in samples of 10, 25, 50, 75, 100, 150, 200, 300 (SAS, 1982) . The model included the main effects of treatment (orthogonal contrasts of C vs R4 + R7 and R4 vs R7), heifer breed (H or Br), calf sex (male or female), and the two-and three-way interactions. The response variables were calf birth weight, calving difficulty score, calf vigour score and gestation length. Incidences of calving difficulty and retained placenta were analysed by routine 2 methods. Daily measures (from 6 days pre partum to 2 days post partum) of cervical diameter and score, pelvic measures, vulva length and hormone concentrations were analysed by least-squares analysis of variance (SAS, 1982) , with a split-plot in time analysis as described by Gill & Hafs (1971) . Data obtained earlier than 6 days pre partum were not included in the analysis because the no. of heifers/group became too low. The whole-plot main effects were treatment (C vs R4 + R7 and R4 vs R7), heifer breed (H or Br), calf sex (male or female) and the two-and three-way inter¬ actions, and were tested by the whole-plot error mean square. Day relative to calving was the sub-plot main effect and was interacted with all whole-plot main effects. The sub-plot regressions were tested by the sub-plot residual mean square. Orthogonal contrasts of C vs R4 + R7 and R4 vs R7 were fitted for both the whole-plot effect of treatment and the subplot regression.
Results

Treatment with relaxin
Heifers assigned to Groups R4 and R7 received treatment 4 or 7 days, respectively, before expected parturition. Actual elapsed times from treatment to calving were 4-81 + 1-3 and 6-86 + 1-33 days respectively.
Blood samples were collected 0, 2, 4, 6, 8 and 24 h after relaxin administration from one heifer in each of Groups R4 and R7 and their respective serum relaxin values are presented in Fig. 2 . Serum relaxin appeared to reach maximum values 2 h after relaxin administration, decreased to half-maximal values by 4 h after treatment, and was undetectable by 24 h after treatment. Daily hormone analyses As shown in Fig. 3 , there were no differences (P > 0-10) in mean hormone concentrations due to the main effects of treatment, heifer breed or calf sex, nor were there any significant (P > 010) twoor three-way interactions. All hormone profiles, except that of relaxin, were characterized by a significant (P = 0-01) cubic sub-plot regression for time. Serum relaxin did not have a significant linear, quadratic or cubic response over time (P > 010), indicating that the serum relaxin profile was not statistically different from a horizontal line equivalent to the detection limits of the assay. These daily samples were collected immediately before treatment on the day of treatment for Group R4 and R7 heifers, and serum concentrations were undetectable by 24 h after treatment (Fig. 2) . The profiles of all hormones measured were not influenced (P > 010) by treatment, breed or sex, and therefore the data presented in Fig. 3 were pooled accordingly.
Daily physical measurements
As shown in Fig. 4 , all four physical measurements changed over time relative to calving and were characterized by a cubic regression (P^001), but were not influenced (P > 010) by relaxin treatment and the data were pooled accordingly (Fig. 4) .
Pelvic area stayed relatively constant until the day of calving when it increased, but it then appeared to decline during the 2 days post partum that measurements were obtained (Fig. 4 ). Relaxin treatment had no effect on pelvic height and width measurements (P > 010) or Fig. 3 . Daily serum concentrations of hormones from 6 days pre partum through 2 days post partum. No differences existed (P > 010) in hormone concentrations or concentration profiles due to treatment, heifer breed or calf sex, therefore the data were pooled accordingly. Fig. 4 . Changes in various physical measurements from 6 days pre partum through 2 days post partum. None of the variables was influenced (P > 0-10) by relaxin treatment, but they all changed over time (P < 0-01) relative to calving as a cubic function. Cervical softness was scored from 1 (firm and non-pliable) to 4 (soft and very pliable). measurements over time relative to calving. Pelvic height was characterized by a cubic sub-plot regression (P^001), whereas pelvic width did not change over time significantly (P > 010) in a linear, quadratic or cubic fashion. Cervical diameter and cervical softness score (Fig. 4 ) began to increase 1 day pre partum and reached maximal values on the day of calving. The statistical analysis indicated that there were no effects (P > 010) of treatment, heifer breed or calf sex on these two variables, nor were there any differences (P > 0-10) in their response over time due to treatment, heifer breed or calf sex. How¬ ever, both cervical diameter and cervical softness score changed over time (P^0-01) as a cubic function (Fig. 4) .
Brahman heifers had longer (P^005) length of the vulva opening (15-2 + 0-43 ví 13-7 + 0-40 cm) than did H heifers, but this measurement was not affected by relaxin treatment or calf sex (P > 0-10). Vulva length (Fig. 4 ) appeared to remain relatively constant except on the day of calving when it increased approximately 3 cm, and then decreased over the 2 days post partum. This change over time for vulva length was not influenced by relaxin treatment or calf sex, but was influenced (P^001) by breed of heifer.
Calving data
Data obtained at the time of calving, as influenced by treatment, are presented in Table 1 . Gestation length was estimated, based on performance data of the service sire, to be 285 days; however, actual gestation length tended to be shorter (P~0-08) for Group C heifers compared with those in Groups R4 and R7. Gestation length was not influenced by breed of heifer, but male calves tended (P~007) to géstate longer than did female calves (286-1 + 115 ví 283-3 ± 0-98 days). Calf birth weight was not affected by relaxin treatment or heifer breed, but male calves were heavier (P^005) at birth than were female calves (42-4 + 1-81 ví 36-9 + 1-54 kg). Calf vigour score (1 to 3) was not affected (P > 010) by treatment, heifer breed or calf sex. Severity of calving difficulty (Table 1 ) tended (P 008) to be less for Group C heifers when compared to Group R4 and R7 heifers, but the incidence of calving difficulty (200 ví 52-4%, C ví R4 + R7) was not statistically different (P > 010). Neither heifer breed nor calf sex influenced (P > 010) severity of calving difficulty or the incidence of calving difficulty. The incidence of placentae being retained longer than 24 h post partum was not affected (P > 010) by treatment, heifer breed or calf sex.
Discussion
Gestation length was not shortened by i.m. administration of pig relaxin 4 or 7 days before expected parturition as it was following intracervical administration of 1 mg at 5 days before expected parturition (Musah et ai, 1986a) . Actually, gestation length tended (P at 008) to be longer for relaxin-treated heifers when compared with untreated controls in the present study. Gestation length was not affected when pig relaxin was administered by i.m. injection at 10 days before expected parturition (Caldwell et ai, 1990 ), or when administered by i.m. injection or by intracervical infusion 4 days pre partum . In the present study, severity of calving difficulty also tended (P = 008) to be greater in heifers receiving pig relaxin i.m., which is in contrast to the effects of pig relaxin given in conjunction with dexamethasone or cloprostenol (Musah et ai, 1988) to induce parturition at 10 days pre partum. The contrast in results between the present study and those reported by Musah et ai (1986a Musah et ai ( , 1988 is not readily explicable, but may result from differences in the route of relaxin administration (i.m. ví intra¬ cervical) and/or the proximity of treatment to the onset of labour.
Intramuscular injection of 1 0 mg pig relaxin resulted in circulating relaxin concentrations of 7-5 ng/ml at 2 h after injection; these fell to~1-5 ng/ml at 8 h and became undetectable by 24 h after injection. Musah et ai (1987a) reported that plasma relaxin concentrations peaked at 3 h (23-1 ng/ml) after i.m. administration and were undetectable by 6 h after injection whereas following infusion into the cervical os, plasma values peaked at 1 h (30-3 ng/ml) and declined to baseline concentration by 24 h after infusion. Following relaxin administration by either route, Musah et ai (1987a) reported a transient decline in plasma progesterone and transient increases in plasma oestrone and oestradiol-17ß concentrations. The relaxin concentrations attained in the present study and that of Musah et ai (1987a) did not approach the values observed near parturition in pigs (Sherwood et ai, 1981) . Whether there is a threshold concentration of circu¬ lating relaxin above which alteration of release of other hormones occurs cannot be presently answered, nor can it be answered whether there is a threshold concentration of relaxin that must be reached to hasten parturition. In the present study, there was no influence of pig relaxin treat¬ ment on the profile of daily serum concentrations of progesterone, oestradiol, PGFM or relaxin (Fig. 3 ) relative to calving, which is in agreement with Musah et ai (1986a) . The serum concen¬ tration profiles of these hormones are consistent with earlier reports in cattle (Smith et ai, 1973; Hunter et ai, 1977) .
Daily determinations of pelvic height, width and area were not affected by relaxin treatment. This finding is in contrast to reports by Musah et ai (1986a, b) following intracervical infusion of pig relaxin 5 days before expected parturition, but is in agreement with for i.m. administration at 4 days pre partum. The contrast in results obtained for pelvic dimensions and area between the present study and those of Musah et ai (1986a, b) is not readily explicable, since we did observe significant changes due to time, heifer breed and calf sex.
Cervical diameter and softness score changed (P^001) over time respective to parturition but were not influenced by pig relaxin treatment, heifer breed or calf sex. did not observe significant relaxin-induced changes of the cervix following i.m. adminis¬ tration. However, and Musah et ai (1986a) report relaxin-induced changes in cervical dilatation after intracervical administration. Cervical diameter estimates were made by rectal palpation rather than by the device described by . It is possible that estimating cervical diameter by rectal palpation is not sufficiently sensitive to detect changes due to treatment, but insertion of a measuring device or infusion instrument into the cervix during the immediate pre-partum period could in itself induce cervical dilatation. Use of an intra¬ cervical device to measure cervical dilatation may actually be measuring cervical extensibility. The effects of relaxin on cervical extensibility have been well docu¬ mented for the rat (Downing & Sherwood, 1985; Hwang & Sherwood, 1988) . Administration of the cervical canal (Evans et ai, 1983) has been reported to enhance cervical softening and dilatation in women. It is possible that the affinity of pig relaxin for the bovine relaxin receptor is low enough that i.m. administration of 1 mg does not provide sufficient pig relaxin at the cervix to elicit a response in cattle, as does local administration within the cervix of cattle and humans.
In the present study, administration of pig relaxin during the pre-partum period did not effec¬ tively change the events of parturition in beef heifers. As yet, bovine relaxin and its role in the progression of parturition is essentially uncharacterized. Fields et ai (1980) reported the purifica¬ tion of bovine relaxin from corpora lutea of late-pregnant cows, but further characterization of the protein has not been reported. Anderson et ai (1982) measured immunoreactive relaxin in serum from late-pregnant heifers, using a pig relaxin RIA, and found relaxin concentrations to be < 200 pg/ml through 1 day pre partum and then rising abruptly to approximately 800 pg/ml on the day of parturition. A similar profile was found in the present study, using essentially an identical RIA, except that our peak concentrations were less (Fig. 3 ) than those reported by Anderson et ai (1982) . The values we obtained for immunoreactive relaxin were below the detection limits of the assay except for the day of and the day preceding calving. Because the assays used by Anderson et ai (1982) and in the present study are both heterologous assays in regard to bovine relaxin, the reliability of these data is questionable. An accurate characterization of the structure of bovine relaxin and its secretion during the periparturient period is needed to delineate its role in parturition.
In conclusion, administration of 1 0 mg pig relaxin ( > 3000 U/mg) by i.m. injection 4 or 7 days before expected parturition did not change periparturient events in beef heifers, which agrees with the results of who also used i.m. administration of pig relaxin but is in contrast to the findings of Musah et ai (1986a, b) who used intracervical administration. An explanation of the cause of these variable results awaits further understanding of the physiological role of relaxin in cattle. Relaxin probably plays an important role during the periparturient period in cattle, but concise elucidation of this role will require further investigation and the characterization of bovine relaxin.
